Case Study: Lyell Immunopharma accelerates cloud security and compliance with Fidelis Security CloudPassage Halo

Lyell Immunopharma - Customer Case Study

Lyell Immunopharma, a publicly traded cell therapy company, faced the challenge of securing its cloud-first operations in a stringently regulated biotech environment. They required a solution to ensure host, network, and cloud security, identify vulnerabilities and compliance issues, and automate workload security without adding management complexity. Lyell selected Fidelis Security and its Fidelis CloudPassage Halo platform to seamlessly integrate security into their automated development and deployment processes.

The implemented solution began with Fidelis Halo Cloud Secure to establish AWS foundations and CIS benchmarks. Lyell then leveraged the platform's API for extensive DevSecOps automation, integrating it into their CI/CD pipeline to catch misconfigurations before production. Fidelis Security’s solution automated policy and compliance across all assets, accelerating Lyell's cloud security implementation by a full year and providing the necessary tools to maintain continuous regulatory compliance.

Lyell Immunopharma

Eric Hoffmann

Staff Software Engineer, DevSecOp